People

To initiate a project and take it all the way to a successful exit requires an organization with the right people in the right positions at the right time.

Trophea is organized to represent all the necessary skills and competences of an innovative and successful biotech company. The company is run as a virtual organization with project management, financing, accounting and administrative support being provided by Aqilion, www.aqilion.com.

Trophea has a highly dedicated and experienced management team and board which are key to the project development. Furthermore, Trophea has active collaborations with the innovators and professional networks, providing the company with world class scientific input.

In addition, Trophea has access to Aqilion’s extensive partner network.


Board

Mats Lidgard, Chairman of the Board

LL.M, Senior Partner in the human venture capital company Lavindia AB. Former international experiences from i.a. the Pharmacia Group, Active Biotech AB and SBL Vaccin AB as general counsel and various other executive management positions. Board member of Scandinavian Biopharma Holding AB, Synphora AB and Lavindia AB, Trophea AB, Trophea Development AB and Redwood Pharma AB.

Anna Törner, Board member

Managing Director of SDS, a Swedish consultancy focused on drug development and biostatistics. Experienced in regulatory affairs and biostatistics from work within regulatory authorities, the pharmaceutical industry and academic research. Main expert area is clinical development and design of clinical trials. MSc (Pharm) and MSc (Math Stat), PhD Medical Science Karolinska.

Jan Faergemann, Board member

MD, PhD, Professor in Dermatology at Sahlgrenska Academy, University of Gothenburg. World leading researcher in dermatology with a special interest in Mycology and Dermato-Pharmacology. Innovator and former board member of Ambria Dermatology AB and innovator in Trophea AB.

Göran Kvist, Board member

M.Sc. (Pharm.), University of Uppsala. CEO of GMP consulting company, TQ Kvalitetskonsult AB. Licensed Qualified Person with focus on quality systems and auditing according to cGMP in the EU, USA and Asia. Board member of AcuCort AB and Trophea AB. Co-founder and board member of QP Support AB. Co-founder of Dilafor AB.

Gudmundur Johannsson, Board member

MD, PhD, Professor of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Senior consultant Department of Endocrinology, Sahlgrenska University Hospital. Editor of the European Journal of Endocrinology, president of the Growth Hormone Research Society. Board member of Trophea AB. Innovator of AcuCort AB, DuoCort Pharma AB and Trophea AB.

Management

Susanna Dahlgren, Project Leader

PhD in clinical immunology from Karolinska Institutet and B.Sc. in microbiology from Stockholm University. She has a robust experience from academic research and pharmaceutical development, and is specialized in project management, medical affairs and scientific communications. Currently Senior Project Leader at AQILION AB. Previously she held the Global Market Intelligence Manager position at Polypeptide Group as well as senior positions with ALK in Denmark and AstraZeneca in Sweden.

Innovators

Jan Faergemann, Main innovator

MD, PhD, Professor in Dermatology at Sahlgrenska Academy, University of Gothenburg. World leading researcher in dermatology with a special interest in Mycology and Dermato-Pharmacology. Innovator and former board member of Ambria Dermatology AB and innovator in Trophea AB.

Gudmundur Johannsson, Innovator

MD, PhD, Professor of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Senior consultant Department of Endocrinology, Sahlgrenska University Hospital. Editor of the European Journal of Endocrinology, president of the Growth Hormone Research Society. Board member of Trophea AB. Innovator of AcuCort AB, DuoCort Pharma AB and Trophea AB.

Jörgen Johnsson, Innovator

Former CEO of Pharmacia Consumer Healthcare worldwide, Senior Vice President of Pharmacia Corporation and member of Pharmacia’s Executive Management Group from 1995-2000. Founder of AQILION AB (legacy P.U.L.S. A), Aqilion advisor and board member of Laccure AB. Innovator in multiple Aqilion project companies.

Claes Ohlsson, Innovator

MD, PhD, Professor at the Department of Internal Medicine, Sahlgrenska Academy, University of Gothenburg. Internationally recognized and award winning researcher in metabolic bone diseases and author of more than 500 peer-reviewed articles. Innovator in Trophea AB.

Jan Törnell, Innovator

MD, PhD. Currently Chief Medical Scientist of AQILION AB (legacy P.U.L.S. AB). Former global Vice President Strategy, AstraZeneca Oncology & Infection. Professor, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg. Chairman of Glactone Pharma AB and LIDDS AB. He serves on the Board of Directors at Diaprost AB and NeuroVive Pharmaceuticals AB, and he is an innovator in Trophea AB.

Greg Batcheller, Innovator

B.Sc. (Econ), J.D, LL.M. Chairman of Xintela AB, Monocl AB, Saga Diagnostics AB and ImmuneBiotech Medical AB. Partner of Business Research Life Sciences Ltd. Advisor to pharmaceutical, biotech, medical device and other high technology companies. Former Project Leader of DuoCort AB and AcuCort AB. Innovator in Laccure AB and Trophea AB.